Samsara BioCapital’s Atreca, Inc. Class A Common Stock BCEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-262,827
| Closed | -$300K | – | 56 |
|
|
2023
Q1 | $300K | Sell |
262,827
-134,008
| -34% | -$153K | 0.06% | 46 |
|
|
2022
Q4 | $318K | Hold |
396,835
| – | – | 0.07% | 48 |
|
|
2022
Q3 | $623K | Hold |
396,835
| – | – | 0.15% | 46 |
|
|
2022
Q2 | $710K | Hold |
396,835
| – | – | 0.19% | 46 |
|
|
2022
Q1 | $1.26M | Hold |
396,835
| – | – | 0.32% | 42 |
|
|
2021
Q4 | $1.2M | Hold |
396,835
| – | – | 0.23% | 39 |
|
|
2021
Q3 | $2.47M | Hold |
396,835
| – | – | 0.39% | 34 |
|
|
2021
Q2 | $3.38M | Hold |
396,835
| – | – | 0.42% | 33 |
|
|
2021
Q1 | $6.08M | Sell |
396,835
-78,108
| -16% | -$1.2M | 1.12% | 19 |
|
|
2020
Q4 | $7.67K | Sell |
474,943
-142,617
| -23% | -$2.3K | 0.77% | 15 |
|
|
2020
Q3 | $8.63M | Buy |
617,560
+107,264
| +21% | +$1.5M | 2.41% | 12 |
|
|
2020
Q2 | $10.9M | Sell |
510,296
-86,542
| -15% | -$1.84M | 3.49% | 10 |
|
|
2020
Q1 | $9.88M | Buy |
596,838
+5,470
| +0.9% | +$90.5K | 5.68% | 7 |
|
|
2019
Q4 | $9.15M | Hold |
591,368
| – | – | 4.38% | 8 |
|
|
2019
Q3 | $7.24M | Hold |
591,368
| – | – | 4.93% | 8 |
|
|
2019
Q2 | $11.1M | Buy |
+591,368
| New | +$11.1M | 7.36% | 7 |
|